{
    "code": "02023280",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023280",
    "time": "2019-09-13 03:03:07",
    "許可證字號": "衛署藥輸字第023280號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/09\/13",
    "發證日期": "90\/09\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202328000",
    "中文品名": "樂伯克錠　０．２５公絲",
    "英文品名": "MIRAPEX TABLETS 0.25MG",
    "適應症": "治療自發性巴金森氏症的徵候及症狀、治療原發性腿部躁動症(PRIMARY RESTLESS LEGS SYNDROME)的症狀。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠鋁箔盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "PRAMIPEXOLE ( PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE)",
    "主製造廠": {
        "申請商名稱": "1405201100  台灣百靈佳殷格翰股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號12樓",
        "主製造廠": "",
        "製造廠名稱": "FDE0021000  BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FDE0021500  BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
            "製造廠廠址": "INGELHEIM AM RHEIN GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7600001520",
            "成分名稱": "PRAMIPEXOLE ( PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE)",
            "含量描述": "(0.25 MG)",
            "含量": "0.1800000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "有",
        "形狀": "橢圓形",
        "標記一": "P7\/P7",
        "標記二": "BI標誌"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Mirapex 0.25 (3)-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023280&Seq=437&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "MR IR PIP006510-010-108-07-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023280&Seq=062&Type=9"
        },
        {
            "title": "020232820001-107-05-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023280&Seq=061&Type=9"
        },
        {
            "title": "MR 0.25 FBP006511-004-108-07-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023280&Seq=005&Type=8"
        },
        {
            "title": "FBP006511-003_0.25-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023280&Seq=004&Type=8"
        }
    ]
}